Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.
Journal
Blood cancer journal
ISSN: 2044-5385
Titre abrégé: Blood Cancer J
Pays: United States
ID NLM: 101568469
Informations de publication
Date de publication:
04 Nov 2020
04 Nov 2020
Historique:
entrez:
5
11
2020
pubmed:
6
11
2020
medline:
6
11
2020
Statut:
epublish
Résumé
A correction to this paper has been published and can be accessed via a link at the top of the paper.
Identifiants
pubmed: 33149116
doi: 10.1038/s41408-020-00374-3
pii: 10.1038/s41408-020-00374-3
pmc: PMC7643148
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
112Commentaires et corrections
Type : ErratumFor